Q3 2017 Evoke Pharma Inc Earnings Call
Llamada en conferencia Evoke Pharma Inc
Evoke Pharma Inc Conference call or earnings call will be held on 14-nov-2017 via an 800 number (toll-free). During the earnings conference call's session Evoke Pharma Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Evoke Pharma Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. We are developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Diabetic gastroparesis is a GI disorder afflicting millions of sufferers worldwide in which the stomach takes too long to empty its contents resulting in serious digestive system symptoms. Metoclopramide is the only product currently approved in the United States to treat the symptoms associated with gastroparesis, and is currently available only in oral and intravenous forms. EVK-001 is a novel formulation of this drug, designed to provide systemic delivery of metoclopramide through nasal administration. Gastroparesis is a condition of delayed gastric emptying in the absence of mechanical obstruction.Leer más Llamada en conferencia